{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T09:09:01Z","timestamp":1793610541313,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-025-06691-w","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T05:30:41Z","timestamp":1741930241000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Altered serum glutathione disulfide levels in acute relapsed schizophrenia are associated with clinical symptoms and response to electroconvulsive therapy"],"prefix":"10.1186","volume":"25","author":[{"given":"Li","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengbing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,14]]},"reference":[{"key":"6691_CR1","doi-asserted-by":"crossref","unstructured":"Vita A, Nibbio G, Barlati S: Conceptualization and characterization of \u201cprimary\u201d and \u201csecondary\u201d cognitive impairment in schizophrenia. Psychiat Res. 2024;340.","DOI":"10.1016\/j.psychres.2024.116126"},{"issue":"5","key":"6691_CR2","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1093\/schbul\/sbad120","volume":"50","author":"K Same","year":"2024","unstructured":"Same K, Shobeiri P, Rashidi M-M, Ghasemi E, Saeedi Moghaddam S, Mohammadi E, Masinaei M, Salehi N, Mohammadi Fateh S, Farzad Maroufi S, et al. A Global, Regional, and National Burden and Quality of Care Index for Schizophrenia: Global Burden of Disease Systematic Analysis 1990\u20132019. Schizophr Bull. 2024;50(5):1083\u201393.","journal-title":"Schizophr Bull"},{"issue":"6","key":"6691_CR3","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S2215-0366(24)00091-9","volume":"11","author":"S Halstead","year":"2024","unstructured":"Halstead S, Cao C, H\u00f8gnason Mohr G, Ebdrup BH, Pillinger T, McCutcheon RA, Firth J, Siskind D, Warren N. Prevalence of multimorbidity in people with and without severe mental illness: a systematic review and meta-analysis. The lancet Psychiatry. 2024;11(6):431\u201342.","journal-title":"The lancet Psychiatry"},{"issue":"1","key":"6691_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.9758\/cpn.23.1084","volume":"22","author":"\u015eA Korkmaz","year":"2023","unstructured":"Korkmaz \u015eA, Kaymak SU, Ne\u015felio\u011flu S, Erel \u00d6. Thiol-disulphide Homeostasis in Patients with Schizophrenia: The Potential Biomarkers of Oxidative Stress in Acute Exacerbation of Schizophrenia. Clinical Psychopharmacology and Neuroscience. 2023;22(1):139\u201350.","journal-title":"Clinical Psychopharmacology and Neuroscience"},{"key":"6691_CR5","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.schres.2024.03.053","volume":"267","author":"H Li","year":"2024","unstructured":"Li H, Huang Y, Liang L, Li H, Li S, Feng Y, Feng S, Wu K, Wu F. The relationship between the gut microbiota and oxidative stress in the cognitive function of schizophrenia: A pilot study in China. Schizophr Res. 2024;267:444\u201350.","journal-title":"Schizophr Res"},{"key":"6691_CR6","doi-asserted-by":"crossref","unstructured":"Yang H, Zhang C, Yang M, Liu J, Zhang Y, Liu D, Zhang X: Variations of plasma oxidative stress levels in male patients with chronic schizophrenia. Correlations with psychopathology and matrix metalloproteinase-9: a case-control study. BMC Psychiatry. 2024:24(1).","DOI":"10.1186\/s12888-023-05479-0"},{"issue":"4","key":"6691_CR7","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/s41380-018-0104-7","volume":"25","author":"J Kumar","year":"2018","unstructured":"Kumar J, Liddle EB, Fernandes CC, Palaniyappan L, Hall EL, Robson SE, Simmonite M, Fiesal J, Katshu MZ, Qureshi A, et al. Glutathione and glutamate in schizophrenia: a 7T MRS study. Mol Psychiatry. 2018;25(4):873\u201382.","journal-title":"Mol Psychiatry"},{"key":"6691_CR8","doi-asserted-by":"crossref","unstructured":"De Simone G, Mazza B, Vellucci L, Barone A, Ciccarelli M, de Bartolomeis A: Schizophrenia Synaptic Pathology and Antipsychotic Treatment in the Framework of Oxidative and Mitochondrial Dysfunction: Translational Highlights for the Clinics and Treatment. Antioxi (Basel). 2023;12(4).","DOI":"10.3390\/antiox12040975"},{"key":"6691_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bbi.2023.09.017","volume":"115","author":"AJ Murray","year":"2024","unstructured":"Murray AJ, Humpston CS, Wilson M, Rogers JC. Zia Ul Haq Katshu M, Liddle PF, Upthegrove R: Measurement of brain glutathione with magnetic Resonance spectroscopy in Schizophrenia-Spectrum disorders \u2014 A systematic review and Meta-Analysis. Brain Behav Immun. 2024;115:3\u201312.","journal-title":"Brain Behav Immun"},{"key":"6691_CR10","doi-asserted-by":"crossref","unstructured":"de Bari L, Scir\u00e8 A, Minnelli C, Cianfruglia L, Kalapos MP, Armeni T: Interplay among Oxidative Stress, Methylglyoxal Pathway and S-Glutathionylation. Antioxidants. 2020;10(1).","DOI":"10.3390\/antiox10010019"},{"issue":"1\u20132","key":"6691_CR11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.mam.2008.05.005","volume":"30","author":"SC Lu","year":"2009","unstructured":"Lu SC. Regulation of glutathione synthesis. Mol Aspects Med. 2009;30(1\u20132):42\u201359.","journal-title":"Mol Aspects Med"},{"issue":"6","key":"6691_CR12","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.3892\/ol.2012.931","volume":"4","author":"O Zitka","year":"2012","unstructured":"Zitka O, Skalickova S, Gumulec J, Masarik M, Adam V, Hubalek J, Trnkova L, Kruseova J, Eckschlager T, Kizek R. Redox status expressed as GSH:GSSG ratio as a marker for oxidative stress in paediatric tumour patients. Oncol Lett. 2012;4(6):1247\u201353.","journal-title":"Oncol Lett"},{"key":"6691_CR13","doi-asserted-by":"crossref","unstructured":"Carletti B, Banaj N, Piras F, Boss\u00f9 P: Schizophrenia and Glutathione: A Challenging Story. J Person Med. 2023;13(11).","DOI":"10.3390\/jpm13111526"},{"key":"6691_CR14","doi-asserted-by":"crossref","unstructured":"Iwata Y, Nakajima S, Plitman E, Truong P, Bani-Fatemi A, Caravaggio F, Kim J, Shah P, Mar W, Chavez S et al: Glutathione Levels and Glutathione-Glutamate Correlation in Patients With Treatment-Resistant Schizophrenia. Schizoph Bulletin Open. 2021;2(1).","DOI":"10.1093\/schizbullopen\/sgab006"},{"key":"6691_CR15","doi-asserted-by":"crossref","unstructured":"Santos-Silva T, Lopes CFB, Hazar \u00dclgen D, Guimar\u00e3es DA, Guimar\u00e3es FS, Alberici LC, Sandi C, Gomes FV: Adolescent Stress-Induced Ventral Hippocampus Redox Dysregulation Underlies Behavioral Deficits and Excitatory\/Inhibitory Imbalance Related to Schizophrenia. Schizophrenia bulletin. 2024.","DOI":"10.1093\/schbul\/sbae033"},{"issue":"5","key":"6691_CR16","first-page":"4136","volume":"55","author":"TV Tran","year":"2018","unstructured":"Tran TV, Shin EJ, Nguyen LTT, Lee Y, Kim DJ, Jeong JH, Jang CG, Nah SY, Toriumi K, Nabeshima T, et al. Protein Kinase C\u03b4 Gene Depletion Protects Against Methamphetamine-Induced Impairments in Recognition Memory and ERK(1\/2) Signaling via Upregulation of Glutathione Peroxidase-1 Gene. Mol Neurobiol. 2018;55(5):4136\u201359.","journal-title":"Mol Neurobiol"},{"key":"6691_CR17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.schres.2024.05.018","volume":"270","author":"E Cecerska-Hery\u0107","year":"2024","unstructured":"Cecerska-Hery\u0107 E, Polikowska A, Serwin N, Michalczyk A, Stodolak P, Goszka M, Zo\u0144 M, Budkowska M, Tyburski E, Podwalski P, et al. The importance of oxidative biomarkers in diagnosis, treatment, and monitoring schizophrenia patients. Schizophr Res. 2024;270:44\u201356.","journal-title":"Schizophr Res"},{"issue":"1\u20133","key":"6691_CR18","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.schres.2013.02.001","volume":"146","author":"A Ballesteros","year":"2013","unstructured":"Ballesteros A, Jiang P, Summerfelt A, Du X, Chiappelli J, O\u2019Donnell P, Kochunov P, Hong LE. No evidence of exogenous origin for the abnormal glutathione redox state in schizophrenia. Schizophr Res. 2013;146(1\u20133):184\u20139.","journal-title":"Schizophr Res"},{"key":"6691_CR19","doi-asserted-by":"crossref","unstructured":"Raffa M, Atig F, Mhalla A, Kerkeni A, Mechri A: Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients. BMC Psychiatry. 2011;11(1).","DOI":"10.1186\/1471-244X-11-124"},{"key":"6691_CR20","doi-asserted-by":"crossref","unstructured":"Aoki N, Tajika A, Suwa T, Kawashima H, Yasuda K, Shimizu T, Uchinuma N, Tominaga H, Tan XW, Koh AHK et al: Relapse Following Electroconvulsive Therapy for Schizophrenia: A Systematic Review and Meta-analysis. Schizoph Bull. 2024.","DOI":"10.2139\/ssrn.4738694"},{"issue":"1","key":"6691_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12888-023-05469-2","volume":"24","author":"Y Wang","year":"2024","unstructured":"Wang Y, Wang G, Gong M, Yang Y, Ling Y, Fang X, Zhu T, Wang Z, Zhang X, Zhang C. Systemic inflammatory biomarkers in Schizophrenia are changed by ECT administration and related to the treatment efficacy. BMC Psychiatry. 2024;24(1):53.","journal-title":"BMC Psychiatry"},{"key":"6691_CR22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.psychres.2018.03.033","volume":"264","author":"HB Ward","year":"2018","unstructured":"Ward HB, Szabo ST, Rakesh G. Maintenance ECT in schizophrenia: A systematic review. Psychiatry Res. 2018;264:131\u201342.","journal-title":"Psychiatry Res"},{"issue":"6","key":"6691_CR23","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1017\/neu.2019.7","volume":"31","author":"A Jorgensen","year":"2019","unstructured":"Jorgensen A, Breitenstein K, Kalliokoski O, Weimann A, Henriksen T, Poulsen HE, Jorgensen MB, W\u00f6rtwein G. Markers of HPA-axis activity and nucleic acid damage from oxidation after electroconvulsive stimulations in rats. Acta Neuropsychiatr. 2019;31(6):287\u201393.","journal-title":"Acta Neuropsychiatr"},{"key":"6691_CR24","doi-asserted-by":"crossref","unstructured":"Alizadeh Makvandi A, Khalili M, Roghani M, Amiri Moghaddam S: Hesperetin ameliorates electroconvulsive therapy-induced memory impairment through regulation of hippocampal BDNF and oxidative stress in a rat model of depression. J Chem Neuroanat. 2021;117.","DOI":"10.1016\/j.jchemneu.2021.102001"},{"key":"6691_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neulet.2018.09.061","volume":"690","author":"B Nielsen","year":"2019","unstructured":"Nielsen B, Cejvanovic V, W\u00f6rtwein G, Hansen AR, Marstal KK, Weimann A, Bjerring PN, Dela F, Poulsen HE, J\u00f8rgensen MB. Increased oxidation of RNA despite reduced mitochondrial respiration after chronic electroconvulsive stimulation of rat brain tissue. Neurosci Lett. 2019;690:1\u20135.","journal-title":"Neurosci Lett"},{"issue":"5","key":"6691_CR26","doi-asserted-by":"publisher","first-page":"456","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_1441_20","volume":"63","author":"M Atagun","year":"2021","unstructured":"Atagun M, Atay OC, Balaban OD, Ipekcioglu D, Alpugan B, Yalcin S, Senat A, Karamustafalioglu N, Ilnem MC, Erel O. Serum nitric oxide levels are depleted in depressed patients treated with electroconvulsive therapy. Indian journal of psychiatry. 2021;63(5):456\u201361.","journal-title":"Indian journal of psychiatry"},{"issue":"2","key":"6691_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5152\/alphapsychiatry.2021.21584","volume":"23","author":"M \u0130lhan Atag\u00fcn","year":"2022","unstructured":"\u0130lhan Atag\u00fcn M, Atay Canbek \u00d6. A Systematic Review of the Literature Regarding the Relationship Between Oxidative Stress and Electroconvulsive Therapy. Alpha psychiatry. 2022;23(2):47\u201356.","journal-title":"Alpha psychiatry"},{"issue":"4","key":"6691_CR28","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1080\/13651501.2020.1777313","volume":"24","author":"NG Usta Saglam","year":"2020","unstructured":"Usta Saglam NG, Aksoy Poyraz C, Yalcin M, Balcioglu I. ECT augmentation of antipsychotics in severely ill schizophrenia: a naturalistic, observational study. Int J Psychiatry Clin Pract. 2020;24(4):392\u20137.","journal-title":"Int J Psychiatry Clin Pract"},{"issue":"6","key":"6691_CR29","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1176\/appi.ajp.2009.09060802","volume":"167","author":"DM Gardner","year":"2010","unstructured":"Gardner DM, Murphy AL, O\u2019Donnell H, Centorrino F, Baldessarini RJ. International consensus study of antipsychotic dosing. Am J Psychiatry. 2010;167(6):686\u201393.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"6691_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.9758\/cpn.2017.15.1.40","volume":"15","author":"M \u015eenyurt","year":"2017","unstructured":"\u015eenyurt M, Aybek H, Herken H, Kaptanoglu B, Korkmaz A. Evaluation of Oxidative Status in Patients Treated with Electroconvulsive Therapy. Clinical Psychopharmacology and Neuroscience. 2017;15(1):40\u20136.","journal-title":"Clinical Psychopharmacology and Neuroscience"},{"issue":"11","key":"6691_CR31","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1016\/j.clinph.2013.05.021","volume":"124","author":"A Ballesteros","year":"2013","unstructured":"Ballesteros A, Summerfelt A, Du X, Jiang P, Chiappelli J, Tagamets M, O\u2019Donnell P, Kochunov P, Hong LE. Electrophysiological intermediate biomarkers for oxidative stress in schizophrenia. Clin Neurophysiol. 2013;124(11):2209\u201315.","journal-title":"Clin Neurophysiol"},{"key":"6691_CR32","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.pnpbp.2013.02.015","volume":"46","author":"JQ Wu","year":"2013","unstructured":"Wu JQ, Kosten TR, Zhang XY. Free radicals, antioxidant defense systems, and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2013;46:200\u20136.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"7\u20138","key":"6691_CR33","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1007\/s12031-023-02140-z","volume":"73","author":"AS Piatoikina","year":"2023","unstructured":"Piatoikina AS, Zhilyaeva TV, Kostina OV, Zhukova ES, Shcherbatyuk TG, Mazo GE. Gender-related Characteristics of Oxidative Stress Severity and Cognitive Impairment in Patients With Schizophrenia. J Mol Neurosci. 2023;73(7\u20138):628\u201334.","journal-title":"J Mol Neurosci"},{"key":"6691_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2022.103400","volume":"79","author":"H Yang","year":"2023","unstructured":"Yang H, Zhang J, Yang M, Xu L, Chen W, Sun Y, Zhang X. Catalase and interleukin-6 serum elevation in a prediction of treatment-resistance in male schizophrenia patients. Asian J Psychiatr. 2023;79: 103400.","journal-title":"Asian J Psychiatr"},{"issue":"8","key":"6691_CR35","first-page":"1202","volume":"19","author":"G Raghu","year":"2021","unstructured":"Raghu G, Berk M, Campochiaro PA, Jaeschke H, Marenzi G, Richeldi L, Wen F-Q, Nicoletti F, Calverley PMA. The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress. Curr Neuropharmacol. 2021;19(8):1202\u201324.","journal-title":"Curr Neuropharmacol"},{"issue":"11","key":"6691_CR36","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1080\/1028415X.2024.2325233","volume":"27","author":"AN Khan","year":"2024","unstructured":"Khan AN, Jawarkar RD, Zaki MEA, Al Mutairi AA. Natural compounds for oxidative stress and neuroprotection in schizophrenia: composition, mechanisms, and therapeutic potential. Nutr Neurosci. 2024;27(11):1306\u201320.","journal-title":"Nutr Neurosci"},{"key":"6691_CR37","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jpsychires.2021.12.049","volume":"146","author":"JN Tsoporis","year":"2022","unstructured":"Tsoporis JN, Ektesabi AM, Gupta S, Izhar S, Salpeas V, Rizos IK, Kympouropoulos SP, dos Santos CC, Parker TG, Rizos E. A longitudinal study of alterations of circulating DJ-1 and miR203a-3p in association to olanzapine medication in a sample of first episode patients with schizophrenia. J Psychiatr Res. 2022;146:109\u201317.","journal-title":"J Psychiatr Res"},{"key":"6691_CR38","doi-asserted-by":"crossref","unstructured":"An X, Shi X: Effects of electroconvulsive shock on neuro-immune responses: Does neuro-damage occur? Psychiat Res. 2020;292.","DOI":"10.1016\/j.psychres.2020.113289"},{"key":"6691_CR39","doi-asserted-by":"crossref","unstructured":"\u0141ukawski K, Czuczwar SJ: Oxidative Stress and Neurodegeneration in Animal Models of Seizures and Epilepsy. Antioxidants. 2023;12(5).","DOI":"10.3390\/antiox12051049"},{"issue":"7","key":"6691_CR40","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.pnpbp.2011.05.007","volume":"35","author":"S Kartalci","year":"2011","unstructured":"Kartalci S, Karabulut AB, Ozcan AC, Porgali E, Unal S. Acute and chronic effects of electroconvulsive treatment on oxidative parameters in schizophrenia patients. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(7):1689\u201394.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"6691_CR41","doi-asserted-by":"crossref","unstructured":"Potkin SG, Kane JM, Correll CU, Lindenmayer J-P, Agid O, Marder SR, Olfson M, Howes OD: The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research. npj Schizophrenia. 2020;6(1).","DOI":"10.1038\/s41537-019-0090-z"},{"key":"6691_CR42","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.brainres.2015.03.018","volume":"1623","author":"PT Ronaldson","year":"2015","unstructured":"Ronaldson PT, Davis TP. Targeting transporters: Promoting blood\u2013brain barrier repair in response to oxidative stress injury. Brain Res. 2015;1623:39\u201352.","journal-title":"Brain Res"},{"issue":"10","key":"6691_CR43","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.1016\/j.apsb.2023.07.010","volume":"13","author":"J Feng","year":"2023","unstructured":"Feng J, Zheng Y, Guo M, Ares I, Mart\u00ednez M, Lopez-Torres B, Mart\u00ednez-Larra\u00f1aga M-R, Wang X, Anad\u00f3n A, Mart\u00ednez M-A. Oxidative stress, the blood\u2013brain barrier and neurodegenerative diseases: The critical beneficial role of dietary antioxidants. Acta Pharmaceutica Sinica B. 2023;13(10):3988\u20134024.","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"6691_CR44","doi-asserted-by":"crossref","unstructured":"Kim S, Jung UJ, Kim SR: Role of Oxidative Stress in Blood\u2013Brain Barrier Disruption and Neurodegenerative Diseases. Antioxidants. 2024;13(12).","DOI":"10.3390\/antiox13121462"},{"issue":"4","key":"6691_CR45","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1007\/s12035-018-1275-6","volume":"56","author":"B Seminotti","year":"2018","unstructured":"Seminotti B, Zanatta \u00c2, Ribeiro RT, da Rosa MS, Wyse ATS, Leipnitz G, Wajner M. Disruption of Brain Redox Homeostasis, Microglia Activation and Neuronal Damage Induced by Intracerebroventricular Administration of S-Adenosylmethionine to Developing Rats. Mol Neurobiol. 2018;56(4):2760\u201373.","journal-title":"Mol Neurobiol"},{"issue":"4","key":"6691_CR46","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/ijnp\/pyaa003","volume":"23","author":"Z Yi","year":"2020","unstructured":"Yi Z, Li Z, He Y, Zhang C, Wang Y, Bao C, Cheng X, Geng R, Zhu M, Huang X, et al. Disturbance of Oxidative Stress Parameters in Treatment-Resistant Bipolar Disorder and Their Association With Electroconvulsive Therapy Response. Int J Neuropsychopharmacol. 2020;23(4):207\u201316.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"3","key":"6691_CR47","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1007\/s12035-021-02718-x","volume":"59","author":"HM Abelaira","year":"2022","unstructured":"Abelaira HM, Rosa T, de Moura AB, Andrade NM, Martinello NS, Maciel LR, Botelho MEM, Borba LA, Chede BC, Arent CO, et al. Combination of electroconvulsive stimulation with ketamine or escitalopram protects the brain against inflammation and oxidative stress induced by maternal deprivation and is critical for associated behaviors in male and female rats. Mol Neurobiol. 2022;59(3):1452\u201375.","journal-title":"Mol Neurobiol"},{"key":"6691_CR48","doi-asserted-by":"crossref","unstructured":"G\u00f3rny M, Bilska-Wilkosz A, Iciek M, Hereta M, Kami\u0144ska K, Kami\u0144ska A, Chwatko G, Rog\u00f3\u017c Z, Lorenc-Koci E: Alterations in the Antioxidant Enzyme Activities in the Neurodevelopmental Rat Model of Schizophrenia Induced by Glutathione Deficiency during Early Postnatal Life. Antioxidants. 2020;9(6).","DOI":"10.3390\/antiox9060538"},{"key":"6691_CR49","doi-asserted-by":"crossref","unstructured":"Goodfellow MJ, Borcar A, Proctor JL, Greco T, Rosenthal RE, Fiskum G: Transcriptional activation of antioxidant gene expression by Nrf2 protects against mitochondrial dysfunction and neuronal death associated with acute and chronic neurodegeneration. Exp Neurol. 2020;328.","DOI":"10.1016\/j.expneurol.2020.113247"},{"key":"6691_CR50","doi-asserted-by":"crossref","unstructured":"G\u00f3rny M, Wnuk A, Kami\u0144ska A, Kami\u0144ska K, Chwatko G, Bilska-Wilkosz A, Iciek M, Kajta M, Rog\u00f3\u017c Z, Lorenc-Koci E: Glutathione Deficiency and Alterations in the Sulfur Amino Acid Homeostasis during Early Postnatal Development as Potential Triggering Factors for Schizophrenia-Like Behavior in Adult Rats. Molecules. 2019;24(23).","DOI":"10.3390\/molecules24234253"},{"key":"6691_CR51","doi-asserted-by":"crossref","unstructured":"Bellanti F, Lo Buglio A, Dobrakowski M, Kasperczyk A, Kasperczyk S, Serviddio G, Vendemiale G: Adherence to Mediterranean Diet and Biomarkers of Redox Balance and Inflammation in Old Patients Hospitalized in Internal Medicine. Nutr. 2024;16(19).","DOI":"10.3390\/nu16193359"},{"key":"6691_CR52","doi-asserted-by":"crossref","unstructured":"Lana JV, Rios A, Takeyama R, Santos N, Pires L, Santos GS, Rodrigues IJ, Jeyaraman M, Purita J, Lana JF: Nebulized Glutathione as a Key Antioxidant for the Treatment of Oxidative Stress in Neurodegenerative Conditions. Nutr. 2024;16(15).","DOI":"10.3390\/nu16152476"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-06691-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-025-06691-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-06691-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T05:30:50Z","timestamp":1741930250000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-025-06691-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6691"],"URL":"https:\/\/doi.org\/10.1186\/s12888-025-06691-w","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,14]]},"assertion":[{"value":"8 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We declare that all experiments on human subjects were conducted in accordance with the Declaration of Helsinki and that all procedures were carried out with the adequate understanding and written consent of the subjects. All experimental protocols were approved by the Ethics Committee of Lian Yun Gang Fourth People\u2019s Hospital. Informed consent was obtained from all the participants and\/or their legal guardians. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"242"}}